speb/financial-data huggingface dataset:
Financial ratios for RAGE.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -7973.722627737226
Operating income: -655575.9124087591
Net income: -626113.1386861313
Capital expenditures: 0
Operating cash flow: -854038.6861313868
Depreciation & amortization: 8573.722627737227
Net tangible assets: 11223264.233576642
Owner earnings: -617539.4160583941
Return on net tangible assets (%): -5.5023155759881455
Buffett classification: The Gruesome
Stock price: 0.2846715328467153
Shares outstanding: 40069229
Book value: 11223264.23357664
P/B ratio: 1.0163325572689472
Market cap (USD): 11406568.839416059
Debt to equity: 0.015518339382637943
Current ratio: 1.344316888525911
Quick ratio: 1.344316888525911
Interest coverage ratio: -111.04587042532147
Free cash flow (dilution-adjusted): -854038.6861313868
Buyback yield (%): 0
Retained earnings: -54734458.394160576
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.767254602285727
Rule of 40 score: 0
Financial ratios for SBT.PA — annual report dated 2022-03-31
Total revenue: 362221111.1111111
Gross profit: 210905555.55555555
Operating income: 59902222.222222224
Net income: 41275555.55555555
Capital expenditures: 25667777.777777776
Operating cash flow: 48466666.666666664
Depreciation & amortization: 20577777.777777776
Net tangible assets: 312323333.3333333
Owner earnings: 36185555.55555555
Return on net tangible assets (%): 11.5859276888979
Capex to operating income (%): 42.84945837661374
Buffett classification: The Good
Stock price: 12.744444444444445
P/E ratio: 19.341868286852595
Shares outstanding: 62642696
Book value: 376221111.11111116
P/B ratio: 2.1220137186465404
Market cap (USD): 798346359.0222223
Debt to equity: 0.20306911715628215
Current ratio: 3.532407571410016
Quick ratio: 1.9366963052180384
Effective tax rate (%): 23.153771218935894
Interest coverage ratio: 38.04657727593507
COGS to revenue (%): 41.77436127104684
SG&A to revenue (%): 18.112938996745388
Free cash flow (dilution-adjusted): 21368888.888888888
Buyback yield (%): 1.065118320793474
Retained earnings: 41275555.55555555
Inventory turnover: 1.0077551503670377
Receivables turnover: 3.5628306010928963
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.030185113124688
FCF margin (%): 5.8994045994006115
Rule of 40 score: 5.8994045994006115
Financial ratios for SBT.PA — annual report dated 2023-03-31
Total revenue: 378520652.173913
Gross profit: 219195652.17391303
Operating income: 59707608.69565217
Net income: 44743478.26086956
Capital expenditures: 19917391.304347824
Operating cash flow: 44585869.56521739
Depreciation & amortization: 21156521.739130434
Net tangible assets: 312065217.3913043
Owner earnings: 45982608.69565217
Return on net tangible assets (%): 14.73493556252177
Capex to operating income (%): 33.3582130308933
Buffett classification: The Good
Stock price: 13.26086956521739
P/E ratio: 18.565758701778254
Shares outstanding: 62642696
Book value: 372859782.6086956
P/B ratio: 2.2279061985651443
Market cap (USD): 830696620.8695651
Debt to equity: 0.17225556873868544
Current ratio: 3.339581023516368
Quick ratio: 1.4171558615860416
Effective tax rate (%): 19.87478301573989
Interest coverage ratio: 31.122379603399434
COGS to revenue (%): 42.0914946344321
R&D to revenue (%): 0.2934766065834097
SG&A to revenue (%): 1.5371626957348261
Free cash flow (dilution-adjusted): 21135869.56521739
Buyback yield (%): 0.0003925463861648967
Retained earnings: 44743478.26086956
Inventory turnover: 0.8898514475816978
Receivables turnover: 4.4341885783408665
Capitalized R&D asset: 1110869.5652173914
ROCI (R&D-adjusted, %): 13.652793496557692
FCF margin (%): 5.583808820953426
Revenue growth (%): 4.499887102881208
Rule of 40 score: 10.083695923834632
Financial ratios for SBT.PA — annual report dated 2024-03-31
Total revenue: 328739784.94623655
Gross profit: 190790322.58064514
Operating income: 46280645.16129032
Net income: 31036559.139784943
Capital expenditures: 22765591.397849463
Operating cash flow: 52387096.77419355
Depreciation & amortization: 22844086.021505374
Net tangible assets: 278773118.27956986
Owner earnings: 31115053.763440855
Return on net tangible assets (%): 11.161425447139733
Capex to operating income (%): 49.190306916660866
Buffett classification: The Good
Stock price: 10.41304347826087
P/E ratio: 21.017185381459075
Shares outstanding: 62642696
Book value: 338667741.93548393
P/B ratio: 1.9260798602062943
Market cap (USD): 652301117.0434783
Debt to equity: 0.32609751683541766
Current ratio: 3.6217472687456413
Quick ratio: 1.6274361076108097
Effective tax rate (%): 23.270473708008616
Interest coverage ratio: 9.669961806335655
COGS to revenue (%): 41.96311754239061
R&D to revenue (%): 0.42979380364245345
SG&A to revenue (%): 1.9160822692066148
Free cash flow (dilution-adjusted): 30224731.182795696
Buyback yield (%): 1.6393576689803537
Retained earnings: 31021505.376344085
Inventory turnover: 0.7870108518952476
Receivables turnover: 3.7175549313586016
Capitalized R&D asset: 2157185.8345021037
ROCI (R&D-adjusted, %): 10.325067666457844
Rosenberg metric: -25.570355406855633
FCF margin (%): 9.194120263763867
Revenue growth (%): -13.15142699395023
Rule of 40 score: -3.957306730186362
Financial ratios for SBT.PA — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 281067777.7777778
Buffett classification: The Gruesome
Stock price: 10.644444444444444
Shares outstanding: 62642696
Book value: 342345555.5555555
P/B ratio: 1.94772996640821
Market cap (USD): 666796697.4222221
Debt to equity: 0.33559009577717125
Current ratio: 3.1738697429300573
Quick ratio: 1.2338631035126666
Buyback yield (%): 0
Retained earnings: 17505555.555555556
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SBT.PA — annual report dated 2025-03-31
Total revenue: 331652173.91304344
Gross profit: 201275000
Operating income: 49671739.13043478
Net income: 32355434.782608695
Capital expenditures: 15440217.391304348
Operating cash flow: 57652173.91304348
Depreciation & amortization: 22142391.304347824
Net tangible assets: 293244565.2173913
Owner earnings: 39057608.69565217
Return on net tangible assets (%): 13.319124488018236
Capex to operating income (%): 31.084511357170992
Buffett classification: The Good
Stock price: 9.543478260869565
P/E ratio: 18.476933210602343
Shares outstanding: 62642696
Book value: 353002173.9130435
P/B ratio: 1.6935567304056507
Market cap (USD): 597829207.4782609
Debt to equity: 0.2943109107592637
Current ratio: 2.315953545712244
Quick ratio: 0.9851905363915477
Effective tax rate (%): 23.248924495736624
Interest coverage ratio: 8.554473979782854
COGS to revenue (%): 39.311418458311486
R&D to revenue (%): 0.3624803356056634
SG&A to revenue (%): 2.295162558993183
Free cash flow (dilution-adjusted): 38639130.43478261
Buyback yield (%): 0
Retained earnings: 32355434.782608695
Inventory turnover: 0.7077604824338837
Receivables turnover: 4.070817712433124
Capitalized R&D asset: 2515406.03085554
ROCI (R&D-adjusted, %): 12.141491043782029
Rosenberg metric: 7.420662100456633
FCF margin (%): 11.650498164656529
Revenue growth (%): 0.885925312411819
Rule of 40 score: 12.536423477068348
Financial ratios for SBT.PA — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 293244565.2173913
Buffett classification: The Gruesome
Stock price: 9.543478260869565
Shares outstanding: 62642696
Book value: 353002173.9130435
P/B ratio: 1.6935567304056507
Market cap (USD): 597829207.4782609
Debt to equity: 0.2943109107592637
Current ratio: 2.315953545712244
Quick ratio: 0.9851905363915477
Buyback yield (%): 0
Retained earnings: 32355434.782608695
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SBT.PA — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 305917647.0588235
Buffett classification: The Gruesome
Stock price: 10.788235294117648
Shares outstanding: 62642696
Book value: 369909411.7647059
P/B ratio: 1.8269449827779776
Market cap (USD): 675804143.9058824
Debt to equity: 0.3260066852615744
Current ratio: 2.0971150643872116
Quick ratio: 0.9096775088809947
Buyback yield (%): 0
Retained earnings: 15796470.588235294
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SLE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22656
Shares outstanding: 1608949
Market cap (USD): 36452348544
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SLE — annual report dated 2022-12-31
Total revenue: 19677000
Gross profit: 8515000
Operating income: -31491000
Net income: -85451000
Capital expenditures: 649000
Operating cash flow: -19826000
Depreciation & amortization: 5403000
Net tangible assets: -862000
Owner earnings: -80697000
Buffett classification: The Gruesome
Stock price: 3225.6
Shares outstanding: 1608949
Book value: 19204000
P/B ratio: 270.24713051447617
Market cap (USD): 5189825894.4
Debt to equity: 0.035357217246406995
Current ratio: 0.9349106892359488
Quick ratio: 0.9349106892359488
Interest coverage ratio: -46.37849779086893
COGS to revenue (%): 56.72612695024648
R&D to revenue (%): 80.68303094983992
SG&A to revenue (%): 115.99329166031407
Free cash flow (dilution-adjusted): -25779000
Buyback yield (%): 0
Retained earnings: -210743000
Receivables turnover: 3.207857841538963
Capitalized R&D asset: 15876000
ROCI (R&D-adjusted, %): -59.07100274065493
FCF margin (%): -131.01082482085684
Rule of 40 score: -131.01082482085684
Financial ratios for SLE — annual report dated 2023-12-31
Total revenue: 25079000
Gross profit: 9782000
Operating income: -22426000
Net income: -30330000
Capital expenditures: 8000
Operating cash flow: -15489000
Depreciation & amortization: 5376000
Net tangible assets: 1490000
Owner earnings: -24962000
Return on net tangible assets (%): -1675.3020134228186
Buffett classification: The Gruesome
Stock price: 729.6
Shares outstanding: 1608949
Book value: 9990000
P/B ratio: 117.50642546546547
Market cap (USD): 1173889190.4
Debt to equity: 0.08008008008008008
Current ratio: 1.253309400942338
Quick ratio: 1.253309400942338
Interest coverage ratio: -448.52
COGS to revenue (%): 60.99525499421827
R&D to revenue (%): 37.880298257506276
SG&A to revenue (%): 87.0927867937318
Free cash flow (dilution-adjusted): -18899000
Buyback yield (%): 0
Retained earnings: -249014000
Receivables turnover: 3.0263062628212865
Capitalized R&D asset: 20136920
ROCI (R&D-adjusted, %): -66.63151982265384
Rosenberg metric: 0.07980599647266313
FCF margin (%): -75.35786913353803
Revenue growth (%): 27.45337195710728
Rule of 40 score: -47.90449717643075
Financial ratios for SLE — quarterly report dated 2024-09-30
Capital expenditures: 23000
Buffett classification: The Gruesome
Stock price: 298.56
Shares outstanding: 1608949
Market cap (USD): 480367813.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SLE — annual report dated 2024-12-31
Total revenue: 16182000
Gross profit: 6102000
Operating income: -16898000
Net income: -16635000
Capital expenditures: 23000
Operating cash flow: -11462000
Depreciation & amortization: 2612000
Net tangible assets: -5764000
Owner earnings: -14046000
Buffett classification: The Gruesome
Stock price: 296.64
Shares outstanding: 1608949
Book value: 170000
P/B ratio: 2807.521360941176
Market cap (USD): 477278631.35999995
Debt to equity: 29.264705882352942
Current ratio: 0.5507898516036381
Quick ratio: 0.5507898516036381
Interest coverage ratio: -30.22898032200358
COGS to revenue (%): 62.291434927697445
R&D to revenue (%): 27.481151897169692
SG&A to revenue (%): 109.89370905944878
Free cash flow (dilution-adjusted): -13226000
Buyback yield (%): 0
Retained earnings: -270035000
Receivables turnover: 4.296866702071163
Capitalized R&D asset: 16051080
ROCI (R&D-adjusted, %): -129.3058644990957
Rosenberg metric: -0.3873684210526316
FCF margin (%): -81.73278951921888
Revenue growth (%): -35.475896168108775
Rule of 40 score: -117.20868568732766
Financial ratios for SLE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 296.64
Shares outstanding: 1608949
Market cap (USD): 477278631.35999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SLE — quarterly report dated 2025-03-31
Total revenue: 2718000
Gross profit: 1196000
Operating income: -3645000
Net income: -4230000
Capital expenditures: 100000
Operating cash flow: -2203000
Depreciation & amortization: 547000
Net tangible assets: -8954000
Owner earnings: -3783000
Buffett classification: The Gruesome
Stock price: 112.8
Shares outstanding: 1608949
Book value: -3461000
Market cap (USD): 181489447.2
Debt to equity: -1.9459693730135799
Current ratio: 0.3321414691022153
Quick ratio: 0.3321414691022153
Interest coverage ratio: -2.5998573466476462
COGS to revenue (%): 55.99705665930832
R&D to revenue (%): 34.17954378219279
SG&A to revenue (%): 132.33995584988963
Free cash flow (dilution-adjusted): -2587000
Buyback yield (%): 0
Retained earnings: -274266000
Receivables turnover: 1.058411214953271
Capitalized R&D asset: 929000
FCF margin (%): -95.18027961736571
Rule of 40 score: -95.18027961736571
Financial ratios for SLE — quarterly report dated 2025-06-30
Total revenue: 3001000
Gross profit: 1309000
Operating income: -3145000
Net income: -2783000
Capital expenditures: 110000
Operating cash flow: -1792000
Depreciation & amortization: 544000
Net tangible assets: -8830000
Owner earnings: -2349000
Buffett classification: The Gruesome
Stock price: 55.62
Shares outstanding: 1608949
Book value: -4117000
Market cap (USD): 89489743.38
Debt to equity: -1.391790138450328
Current ratio: 0.30251964676334764
Quick ratio: 0.30251964676334764
COGS to revenue (%): 56.38120626457847
R&D to revenue (%): 23.125624791736087
SG&A to revenue (%): 120.92635788070642
Free cash flow (dilution-adjusted): -2377000
Buyback yield (%): 0
Retained earnings: -277149000
Receivables turnover: 1.284124946512623
Capitalized R&D asset: 1316430
Rosenberg metric: 0.1216361679224973
FCF margin (%): -79.20693102299234
Revenue growth (%): 10.412067696835908
Rule of 40 score: -68.79486332615643
Financial ratios for SLE — quarterly report dated 2025-09-30
Total revenue: 2423000
Gross profit: 1080000
Operating income: -3051000
Net income: 3544000
Capital expenditures: 25000
Operating cash flow: -2810000
Depreciation & amortization: 516000
Net tangible assets: -6230000
Owner earnings: 4035000
Return on net tangible assets (%): -64.76725521669341
Buffett classification: The Gruesome
Stock price: 53.88
P/E ratio: 6.115277378668172
Shares outstanding: 1608949
Book value: -2005000
Market cap (USD): 86690172.12
Debt to equity: -1.6478802992518704
Current ratio: 0.4647242455775234
Quick ratio: 0.4647242455775234
Interest coverage ratio: -3.020792079207921
COGS to revenue (%): 55.42715641766405
R&D to revenue (%): 27.52785802723896
SG&A to revenue (%): 137.68056128765994
Free cash flow (dilution-adjusted): -3448000
Buyback yield (%): 0
Retained earnings: -273605000
Receivables turnover: 1.2632950990615224
Capitalized R&D asset: 1438550
ROCI (R&D-adjusted, %): -593.2208714227374
Rosenberg metric: -0.329971181556196
FCF margin (%): -142.30293025175402
Revenue growth (%): -19.260246584471844
Rule of 40 score: -161.56317683622586
Financial ratios for SLE — quarterly report dated 2025-12-31
Total revenue: 3200000
Gross profit: 1008000
Operating income: -3226000
Net income: -10142000
Capital expenditures: 0
Operating cash flow: -3867000
Depreciation & amortization: 586000
Net tangible assets: 13885000
Owner earnings: -9556000
Return on net tangible assets (%): -68.82247029168167
Buffett classification: The Gruesome
Stock price: 7.33
Shares outstanding: 1608949
Book value: 17534000
P/B ratio: 0.672612990190487
Market cap (USD): 11793596.17
Debt to equity: 0
Current ratio: 4.356937799043062
Quick ratio: 4.356937799043062
Interest coverage ratio: -0.5199871050934881
COGS to revenue (%): 68.5
R&D to revenue (%): 19.4375
SG&A to revenue (%): 108.8125
Free cash flow (dilution-adjusted): -4813000
Buyback yield (%): 0
Retained earnings: -289962000
Receivables turnover: 1.3045250713412149
Capitalized R&D asset: 1297910
ROCI (R&D-adjusted, %): -17.19605770501888
Rosenberg metric: -0.10794602698650675
FCF margin (%): -150.40625
Revenue growth (%): 32.06768468840281
Rule of 40 score: -118.3385653115972
Financial ratios for SLE — annual report dated 2025-12-31
Total revenue: 11342000
Gross profit: 4593000
Operating income: -13067000
Net income: -19927000
Capital expenditures: 0
Operating cash flow: -10672000
Depreciation & amortization: 2193000
Net tangible assets: 13885000
Owner earnings: -17734000
Return on net tangible assets (%): -127.72056175729205
Buffett classification: The Gruesome
Stock price: 7.33
Shares outstanding: 1608949
Book value: 17534000
P/B ratio: 0.672612990190487
Market cap (USD): 11793596.17
Debt to equity: 0
Current ratio: 4.356937799043062
Quick ratio: 4.356937799043062
Interest coverage ratio: -1.5491404860699467
COGS to revenue (%): 59.504496561453
R&D to revenue (%): 25.674484217950976
SG&A to revenue (%): 125.37471345441722
Free cash flow (dilution-adjusted): -13225000
Buyback yield (%): 0
Retained earnings: -289962000
Receivables turnover: 4.623726049735018
Capitalized R&D asset: 9026490
ROCI (R&D-adjusted, %): -59.04689252065624
Rosenberg metric: -0.3393298853159433
FCF margin (%): -116.60201022747312
Revenue growth (%): -29.909776294648378
Rule of 40 score: -146.5117865221215
Financial ratios for SVCT.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.010945945945945949
Shares outstanding: 24978039
Market cap (USD): 273408.2647297298
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SVCT.L — annual report dated 2022-12-31
Total revenue: -3073493.9759036144
Net income: -3312048.1927710846
Capital expenditures: 0
Operating cash flow: -579518.0722891566
Net tangible assets: 21843373.493975904
Owner earnings: -3312048.1927710846
Return on net tangible assets (%): -15.162713734142308
Buffett classification: The Gruesome
Stock price: 0.008072289156626507
Shares outstanding: 24978039
Book value: 21843373.493975908
P/B ratio: 0.009230714908990622
Market cap (USD): 201629.953373494
Debt to equity: 0
Free cash flow (dilution-adjusted): -579518.0722891566
Buyback yield (%): 14.938495706496772
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SVCT.L — annual report dated 2023-12-31
Total revenue: -3062025.3164556962
Net income: -3381012.658227848
Capital expenditures: 0
Operating cash flow: -581012.6582278481
Net tangible assets: 21382278.481012657
Owner earnings: -3381012.658227848
Return on net tangible assets (%): -15.812218801799668
Buffett classification: The Gruesome
Stock price: 0.008354430379746834
Shares outstanding: 24978039
Book value: 21382278.481012657
P/B ratio: 0.009759356938195594
Market cap (USD): 208677.28784810123
Debt to equity: 0
Free cash flow (dilution-adjusted): -581012.6582278481
Buyback yield (%): 46.1011031136252
Receivables turnover: -806.3333333333335
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SVCT.L — annual report dated 2024-12-31
Total revenue: -4390000
Net income: -4677500
Capital expenditures: 0
Operating cash flow: -321250
Net tangible assets: 17422500
Owner earnings: -4677500
Return on net tangible assets (%): -26.847467355431192
Buffett classification: The Gruesome
Stock price: 0.00575
Shares outstanding: 24978039
Book value: 17422500
P/B ratio: 0.008243577227722771
Market cap (USD): 143623.72425
Debt to equity: 0
Free cash flow (dilution-adjusted): -321250
Buyback yield (%): 142.73407897651003
Receivables turnover: -319.27272727272725
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SVCT.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 17422500
Buffett classification: The Gruesome
Stock price: 0.00575
Shares outstanding: 24978039
Book value: 17422500
P/B ratio: 0.008243577227722771
Market cap (USD): 143623.72425
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TG1.AX — annual report dated 2021-06-30
Operating income: -1628790.977443609
Net income: -1628790.977443609
Capital expenditures: 13847.368421052632
Net tangible assets: 4453572.932330827
Owner earnings: -1642638.3458646615
Return on net tangible assets (%): -36.88360718065009
Buffett classification: The Gruesome
Stock price: 0.14285714285714285
Shares outstanding: 463101661
Book value: 4453572.932330827
P/B ratio: 14.854899908023498
Market cap (USD): 66157380.14285714
Debt to equity: 0
Current ratio: 145.1812435500516
Quick ratio: 145.1812435500516
Free cash flow (dilution-adjusted): -1408390.2255639096
Buyback yield (%): 0
Retained earnings: -2115221.052631579
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -36.5726800075364
Rule of 40 score: 0
Financial ratios for TG1.AX — annual report dated 2022-06-30
Operating income: -1036033.7931034483
Net income: -1030818.6206896552
Capital expenditures: 985391.0344827586
Net tangible assets: 3421324.1379310344
Owner earnings: -2016209.6551724137
Return on net tangible assets (%): -58.93068221217032
Buffett classification: The Gruesome
Stock price: 0.08965517241379312
Shares outstanding: 463101661
Book value: 3421324.137931035
P/B ratio: 12.135494208735476
Market cap (USD): 41519459.26206897
Debt to equity: 0
Current ratio: 29.489012722111244
Quick ratio: 29.489012722111244
Free cash flow (dilution-adjusted): -1682751.0344827587
Buyback yield (%): 0
Retained earnings: -2970986.896551724
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -30.2816614660184
Rule of 40 score: 0
Financial ratios for TG1.AX — annual report dated 2023-06-30
Operating income: -1400709.2715231788
Net income: -1391243.7086092716
Capital expenditures: 80072.18543046358
Net tangible assets: 3722716.5562913907
Owner earnings: -1471315.8940397352
Return on net tangible assets (%): -39.522640840147
Buffett classification: The Gruesome
Stock price: 0.039735099337748346
Shares outstanding: 463101661
Book value: 3722716.5562913907
P/B ratio: 4.943000689164183
Market cap (USD): 18401390.503311258
Debt to equity: 0
Current ratio: 7.47833805752218
Quick ratio: 7.47833805752218
Free cash flow (dilution-adjusted): -1968630.463576159
Buyback yield (%): 0.6586026906951646
Retained earnings: -4244178.145695364
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -37.62599838969691
Rule of 40 score: 0
Financial ratios for TG1.AX — annual report dated 2024-06-30
Operating income: -1115902.6666666667
Net income: -1096785.3333333333
Capital expenditures: 11477.333333333334
Net tangible assets: 4479525.333333333
Owner earnings: -1108262.6666666665
Return on net tangible assets (%): -24.740627280747603
Buffett classification: The Gruesome
Stock price: 0.02
Shares outstanding: 463101661
Book value: 4456110.666666667
P/B ratio: 2.0785016156091873
Market cap (USD): 9262033.22
Debt to equity: 0
Current ratio: 15.021624033672227
Quick ratio: 15.021624033672227
Free cash flow (dilution-adjusted): -1254247.3333333333
Buyback yield (%): 1.493279031879784
Retained earnings: -4464633.333333333
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.04207705194635
Rule of 40 score: 0
Financial ratios for TMO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 658.54
Shares outstanding: 371621465
Market cap (USD): 244727599561.09998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TMO — annual report dated 2022-12-31
Total revenue: 44915000000
Gross profit: 18971000000
Operating income: 8507000000
Net income: 6960000000
Capital expenditures: 2219000000
Operating cash flow: 9154000000
Depreciation & amortization: 3381000000
Net tangible assets: -14660000000
Owner earnings: 8122000000
Return on net tangible assets (%): -55.4024556616644
Capex to operating income (%): 26.084401081462328
Buffett classification: The Good
Stock price: 544.71
P/E ratio: 29.084185086228448
Shares outstanding: 371621465
Book value: 44148000000
P/B ratio: 4.585166444689454
Market cap (USD): 202425928200.15002
Debt to equity: 0.7811905409078554
Current ratio: 1.4831863609641387
Quick ratio: 1.1519694297472076
Effective tax rate (%): 8.972559029993619
Interest coverage ratio: 11.717630853994491
COGS to revenue (%): 57.762440164755645
R&D to revenue (%): 3.2750751419347655
SG&A to revenue (%): 20.022264276967604
Free cash flow (dilution-adjusted): 6604000000
Buyback yield (%): 1.4820235859478088
Retained earnings: 41910000000
Inventory turnover: 4.604898828541001
Receivables turnover: 4.764506205579718
Capitalized R&D asset: 1471000000
ROCI (R&D-adjusted, %): 11.624905552492393
FCF margin (%): 14.703328509406658
Rule of 40 score: 14.703328509406658
Financial ratios for TMO — annual report dated 2023-12-31
Total revenue: 42857000000
Gross profit: 17100000000
Operating income: 7318000000
Net income: 5995000000
Capital expenditures: 1392000000
Operating cash flow: 8406000000
Depreciation & amortization: 3406000000
Net tangible assets: -13955000000
Owner earnings: 8009000000
Return on net tangible assets (%): -57.391615908276606
Capex to operating income (%): 19.021590598524188
Buffett classification: The Great
Stock price: 526.44
P/E ratio: 32.63326172386989
Shares outstanding: 371621465
Book value: 46842000000
P/B ratio: 4.176516887293455
Market cap (USD): 195636404034.6
Debt to equity: 0.7454207762264634
Current ratio: 1.7548529831572937
Quick ratio: 1.3917356551527262
Effective tax rate (%): 4.509368053350269
Interest coverage ratio: 5.322181818181818
COGS to revenue (%): 60.09986699955666
R&D to revenue (%): 3.1196770655902184
SG&A to revenue (%): 19.705065683552277
Free cash flow (dilution-adjusted): 6649000000
Buyback yield (%): 1.5334569324170484
Retained earnings: 47364000000
Inventory turnover: 5.062303459119497
Receivables turnover: 4.434706125827814
Capitalized R&D asset: 2322570000
ROCI (R&D-adjusted, %): 8.86868588686342
Rosenberg metric: -1.2719238613188306
FCF margin (%): 15.51438504795016
Revenue growth (%): -4.581988199933207
Rule of 40 score: 10.932396848016953
Financial ratios for TMO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 614.71
Shares outstanding: 371621465
Market cap (USD): 228439430750.15002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TMO — annual report dated 2024-12-31
Total revenue: 42879000000
Gross profit: 17702000000
Operating income: 7717000000
Net income: 6338000000
Capital expenditures: 1343000000
Operating cash flow: 8667000000
Depreciation & amortization: 3108000000
Net tangible assets: -11801000000
Owner earnings: 8103000000
Return on net tangible assets (%): -68.66367257012118
Capex to operating income (%): 17.403135933652976
Buffett classification: The Great
Stock price: 517.37
P/E ratio: 30.335405072112653
Shares outstanding: 371621465
Book value: 49672000000
P/B ratio: 3.870707790043687
Market cap (USD): 192265797347.05
Debt to equity: 0.6296303752617168
Current ratio: 1.6604410441044104
Quick ratio: 1.287053705370537
Effective tax rate (%): 9.336364928236463
Interest coverage ratio: 5.551798561151079
COGS to revenue (%): 58.71638797546584
R&D to revenue (%): 3.2416800764943217
SG&A to revenue (%): 20.04477716364654
Free cash flow (dilution-adjusted): 6966000000
Buyback yield (%): 2.0804532346331923
Retained earnings: 53102000000
Inventory turnover: 5.057653676175171
Receivables turnover: 4.454498233949719
Capitalized R&D asset: 2771220000
ROCI (R&D-adjusted, %): 8.88387174060493
Rosenberg metric: 0.450261780104712
FCF margin (%): 16.24571468551039
Revenue growth (%): 0.05133350444501482
Rule of 40 score: 16.297048189955404
Financial ratios for TMO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 517.37
Shares outstanding: 371621465
Market cap (USD): 192265797347.05
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TMO — quarterly report dated 2025-03-31
Total revenue: 10364000000
Gross profit: 4235000000
Operating income: 1815000000
Net income: 1511000000
Capital expenditures: 350000000
Operating cash flow: 723000000
Depreciation & amortization: 705000000
Net tangible assets: -12426000000
Owner earnings: 1866000000
Return on net tangible assets (%): -15.016900048285853
Capex to operating income (%): 19.28374655647383
Buffett classification: The Great
Stock price: 495.28
P/E ratio: 30.452792717604233
Shares outstanding: 371621465
Book value: 49485000000
P/B ratio: 3.7194438554147715
Market cap (USD): 184056679185.19998
Debt to equity: 0.690896231181166
Current ratio: 1.7745559435251252
Quick ratio: 1.3780173068164567
Effective tax rate (%): 5.864197530864197
Interest coverage ratio: 5.99009900990099
COGS to revenue (%): 59.13739868776534
R&D to revenue (%): 3.299884214588962
SG&A to revenue (%): 20.050173678116558
Free cash flow (dilution-adjusted): 286000000
Buyback yield (%): 1.0866217997922134
Retained earnings: 54447000000
Inventory turnover: 1.173238897396631
Receivables turnover: 1.0552896853680889
Capitalized R&D asset: 342000000
ROCI (R&D-adjusted, %): 2.3698221763388974
FCF margin (%): 2.7595522964106523
Rule of 40 score: 2.7595522964106523
Financial ratios for TMO — quarterly report dated 2025-06-30
Total revenue: 10854000000
Gross profit: 4408000000
Operating income: 1916000000
Net income: 1618000000
Capital expenditures: 293000000
Operating cash flow: 1399000000
Depreciation & amortization: 686000000
Net tangible assets: -11886000000
Owner earnings: 2011000000
Return on net tangible assets (%): -16.919064445566214
Capex to operating income (%): 15.292275574112734
Buffett classification: The Great
Stock price: 403.99
P/E ratio: 47.980618614685206
Shares outstanding: 371621465
Book value: 50602000000
P/B ratio: 2.9669055698460536
Market cap (USD): 150131355645.35
Debt to equity: 0.6961977787439232
Current ratio: 1.9330083346438118
Quick ratio: 1.4959113068092467
Effective tax rate (%): 5.3832650672908136
Interest coverage ratio: 4.742574257425742
COGS to revenue (%): 59.38824396535839
R&D to revenue (%): 3.2430440390639395
SG&A to revenue (%): 19.716233646581905
Free cash flow (dilution-adjusted): 1024000000
Buyback yield (%): 0
Retained earnings: 55901000000
Inventory turnover: 1.159561072135276
Receivables turnover: 1.0816143497757849
Capitalized R&D asset: 581140000
ROCI (R&D-adjusted, %): 2.2859971785332367
Rosenberg metric: 0.5058479532163743
FCF margin (%): 9.43430993182237
Revenue growth (%): 4.727904284060208
Rule of 40 score: 14.162214215882578
Financial ratios for TMO — quarterly report dated 2025-09-30
Total revenue: 11122000000
Gross profit: 4583000000
Operating income: 2075000000
Net income: 1621000000
Capital expenditures: 400000000
Operating cash flow: 2239000000
Depreciation & amortization: 661000000
Net tangible assets: -14511000000
Owner earnings: 1882000000
Return on net tangible assets (%): -12.96947143546275
Capex to operating income (%): 19.27710843373494
Buffett classification: The Great
Stock price: 483.69
P/E ratio: 37.84201819070526
Shares outstanding: 371621465
Book value: 51154000000
P/B ratio: 3.5138911210433204
Market cap (USD): 179749586405.85
Debt to equity: 0.6975016616491378
Current ratio: 1.497514777001612
Quick ratio: 1.1116335303600215
Effective tax rate (%): 11.336254107338444
Interest coverage ratio: 5.979827089337176
COGS to revenue (%): 58.793382485164535
R&D to revenue (%): 3.110951267757598
SG&A to revenue (%): 19.438949829167417
Free cash flow (dilution-adjusted): 1765000000
Buyback yield (%): 0.5357453217309094
Retained earnings: 57354000000
Inventory turnover: 1.138207136640557
Receivables turnover: 1.0561200265881683
Capitalized R&D asset: 694700000
ROCI (R&D-adjusted, %): 2.3352588054417573
Rosenberg metric: 0.4971590909090909
FCF margin (%): 15.869447941017803
Revenue growth (%): 2.4691358024691357
Rule of 40 score: 18.33858374348694
Financial ratios for TMO — quarterly report dated 2025-12-31
Total revenue: 12215000000
Gross profit: 5011000000
Operating income: 2303000000
Net income: 1970000000
Capital expenditures: 438000000
Operating cash flow: 3457000000
Depreciation & amortization: 728000000
Net tangible assets: -11793000000
Owner earnings: 2260000000
Return on net tangible assets (%): -19.16391079453913
Capex to operating income (%): 19.018671298306554
Buffett classification: The Great
Stock price: 578.3
P/E ratio: 31.980460299032732
Shares outstanding: 371621465
Book value: 53536000000
P/B ratio: 4.014283719543858
Market cap (USD): 214908693209.49997
Debt to equity: 0.7356731918708906
Current ratio: 1.8899861742050168
Quick ratio: 1.5328198038053855
Effective tax rate (%): 7.106363214119833
Interest coverage ratio: 6.30958904109589
COGS to revenue (%): 58.97666803110929
R&D to revenue (%): 2.9144494474007367
SG&A to revenue (%): 19.255014326647565
Free cash flow (dilution-adjusted): 2908000000
Buyback yield (%): 0.01721661392446847
Retained earnings: 59156000000
Inventory turnover: 1.327926267281106
Receivables turnover: 1.1560666288093886
Capitalized R&D asset: 703980000
ROCI (R&D-adjusted, %): 2.4073808635093985
Rosenberg metric: 1.2369942196531791
FCF margin (%): 23.806794924273433
Revenue growth (%): 9.827369178205359
Rule of 40 score: 33.63416410247879
Financial ratios for TMO — annual report dated 2025-12-31
Total revenue: 44557000000
Gross profit: 18239000000
Operating income: 8110000000
Net income: 6721000000
Capital expenditures: 1481000000
Operating cash flow: 7818000000
Depreciation & amortization: 2780000000
Net tangible assets: -11793000000
Owner earnings: 8020000000
Return on net tangible assets (%): -68.00644450097515
Capex to operating income (%): 18.261405672009865
Buffett classification: The Great
Stock price: 578.3
P/E ratio: 31.975702010043143
Shares outstanding: 371621465
Book value: 53536000000
P/B ratio: 4.014283719543858
Market cap (USD): 214908693209.49997
Debt to equity: 0.7356731918708906
Current ratio: 1.8899861742050168
Quick ratio: 1.5328198038053855
Effective tax rate (%): 7.484948002189381
Interest coverage ratio: 5.715292459478506
COGS to revenue (%): 59.06591556882196
R&D to revenue (%): 3.1353098278609424
SG&A to revenue (%): 19.597369661332674
Free cash flow (dilution-adjusted): 5983000000
Buyback yield (%): 1.3959416695514977
Retained earnings: 59156000000
Inventory turnover: 4.851244239631336
Receivables turnover: 4.217016846488738
Capitalized R&D asset: 2769510000
ROCI (R&D-adjusted, %): 8.304781286264488
Rosenberg metric: 0.38633093525179857
FCF margin (%): 13.42774423771798
Revenue growth (%): 3.9133375311924254
Rule of 40 score: 17.341081768910406
Financial ratios for TRY.L — annual report dated 2022-03-31
Total revenue: 377985526.31578946
Net income: 370640789.4736842
Capital expenditures: 0
Operating cash flow: 141761842.10526314
Net tangible assets: 2056235526.3157895
Owner earnings: 370640789.4736842
Return on net tangible assets (%): 18.02521086374628
Buffett classification: The Gruesome
Stock price: 0.04776315789473684
P/E ratio: 0.0408958900268738
Shares outstanding: 317350980
Book value: 2056235526.3157895
P/B ratio: 0.007371570411949788
Market cap (USD): 15157684.965789473
Debt to equity: 0.05903289032909526
Effective tax rate (%): 0.6762927310872516
COGS to revenue (%): 0
SG&A to revenue (%): 0.6958634589879172
Free cash flow (dilution-adjusted): 141761842.10526314
Buyback yield (%): 0
Retained earnings: 543334210.5263158
Receivables turnover: 8.54077597740449
Capitalized R&D asset: 0
FCF margin (%): 37.504568888393806
Rule of 40 score: 37.504568888393806
Financial ratios for TRY.L — annual report dated 2023-03-31
Total revenue: -667048148.1481481
Net income: -675637037.037037
Capital expenditures: 0
Operating cash flow: 91448148.14814815
Net tangible assets: 1195488888.8888888
Owner earnings: -675637037.037037
Return on net tangible assets (%): -56.51554299806061
Buffett classification: The Gruesome
Stock price: 0.028641975308641973
Shares outstanding: 317350980
Book value: 1195488888.8888888
P/B ratio: 0.007603214900459133
Market cap (USD): 9089558.933333334
Debt to equity: 0.07118633215813355
Free cash flow (dilution-adjusted): 91448148.14814815
Buyback yield (%): 0
Retained earnings: -123174074.07407406
Receivables turnover: -117.7913669064748
Capitalized R&D asset: 0
Revenue growth (%): -276.47452129975477
Rule of 40 score: -276.47452129975477
Financial ratios for TRY.L — annual report dated 2024-03-31
Total revenue: 35935540.56962025
Net income: 248540506.3291139
Capital expenditures: 0
Operating cash flow: 56986075.94936708
Net tangible assets: 1412029113.9240506
Owner earnings: 248540506.3291139
Return on net tangible assets (%): 17.601655934587356
Buffett classification: The Gruesome
Stock price: 0.036075949367088606
P/E ratio: 0.046063871258537184
Shares outstanding: 317350980
Book value: 1412029113.9240506
P/B ratio: 0.008108004129078989
Market cap (USD): 11448737.88607595
Debt to equity: 0.051768574356142474
Effective tax rate (%): 1.1249817454842104
COGS to revenue (%): 0
SG&A to revenue (%): 6.495455969745942
Free cash flow (dilution-adjusted): 56986075.94936708
Buyback yield (%): 0
Retained earnings: 1201306329.113924
Receivables turnover: 6.887209376516254
Capitalized R&D asset: 0
FCF margin (%): 158.57859669305452
Rule of 40 score: 158.57859669305452
Financial ratios for TRY.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1602029333.3333333
Buffett classification: The Gruesome
Stock price: 0.04293333333333333
Shares outstanding: 317350980
Book value: 1602029333.3333333
P/B ratio: 0.00850479771156916
Market cap (USD): 13624935.408
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 1380068000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TRY.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 1348359740.25974
Buffett classification: The Gruesome
Stock price: 0.035194805194805195
Shares outstanding: 317350980
Book value: 1348359740.25974
P/B ratio: 0.008283476275648047
Market cap (USD): 11169105.91948052
Debt to equity: 0.11923192874074032
Buyback yield (%): 0
Retained earnings: 1132163636.3636363
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TRY.L — annual report dated 2025-03-31
Total revenue: -30055844.155844156
Net income: -35637662.33766234
Capital expenditures: 0
Operating cash flow: -30490909.09090909
Net tangible assets: 1348359740.25974
Owner earnings: -35637662.33766234
Return on net tangible assets (%): -2.643038150248932
Buffett classification: The Gruesome
Stock price: 0.035194805194805195
Shares outstanding: 317350980
Book value: 1348359740.25974
P/B ratio: 0.008283476275648047
Market cap (USD): 11169105.91948052
Debt to equity: 0.11923192874074032
Free cash flow (dilution-adjusted): -30490909.09090909
Buyback yield (%): 0
Retained earnings: 1132163636.3636363
Receivables turnover: -85.0845588235294
Capitalized R&D asset: 0
Revenue growth (%): -183.63821353296473
Rule of 40 score: -183.63821353296473
Financial ratios for TRY.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 1506806756.7567568
Buffett classification: The Gruesome
Stock price: 0.041081081081081085
Shares outstanding: 317350980
Book value: 1506806756.7567568
P/B ratio: 0.008652152163560491
Market cap (USD): 13037121.340540541
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 1281845945.945946
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TT8.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 93.0909090909091
Shares outstanding: 426999732
Market cap (USD): 39749793233.454544
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TT8.DE — annual report dated 2022-12-31
Total revenue: 1577795000
Gross profit: 1296672000
Operating income: 113654000
Net income: 53385000
Capital expenditures: 84160000
Operating cash flow: 548734000
Depreciation & amortization: 54425000
Net tangible assets: 2096795000
Owner earnings: 23650000
Return on net tangible assets (%): 1.127911884566684
Capex to operating income (%): 74.04930754746863
Buffett classification: The Good
Stock price: 44.72340425531915
P/E ratio: 357.7199893443652
Shares outstanding: 426999732
Book value: 2115339000
P/B ratio: 9.027811443531716
Market cap (USD): 19096881631.148937
Debt to equity: 0.12336415108878529
Current ratio: 1.8950245968729473
Quick ratio: 1.8950245968729473
Effective tax rate (%): 58.08667661144696
COGS to revenue (%): 17.817460443213474
R&D to revenue (%): 20.2736096894717
SG&A to revenue (%): 54.70558596015324
Free cash flow (dilution-adjusted): -41793000
Buyback yield (%): 0
Retained earnings: 665514000
Receivables turnover: 0.6722044823715115
Capitalized R&D asset: 319876000
ROCI (R&D-adjusted, %): 12.237973589215265
FCF margin (%): -2.648823199465076
Rule of 40 score: -2.648823199465076
Financial ratios for TT8.DE — annual report dated 2023-12-31
Total revenue: 1946120000
Gross profit: 1580522000
Operating income: 200480000
Net income: 178940000
Capital expenditures: 46790000
Operating cash flow: 598322000
Depreciation & amortization: 80418000
Net tangible assets: 2147318000
Owner earnings: 212568000
Return on net tangible assets (%): 9.899232437859693
Capex to operating income (%): 23.33898643256185
Buffett classification: The Great
Stock price: 73.8
P/E ratio: 176.10696446630155
Shares outstanding: 426999732
Book value: 2164219000
P/B ratio: 14.560716924488696
Market cap (USD): 31512580221.6
Debt to equity: 0.10899682518266404
Current ratio: 1.718133149171711
Quick ratio: 1.718133149171711
Effective tax rate (%): 33.23009757644732
COGS to revenue (%): 18.78599469714098
R&D to revenue (%): 21.159743489610097
SG&A to revenue (%): 49.75273878280887
Free cash flow (dilution-adjusted): 51681000
Buyback yield (%): 2.051869429456609
Retained earnings: 196954000
Receivables turnover: 0.6780166483585588
Capitalized R&D asset: 626110920
ROCI (R&D-adjusted, %): 12.263279464793925
Rosenberg metric: 0.8873751078542935
FCF margin (%): 2.6555916387478677
Revenue growth (%): 23.34428743911598
Rule of 40 score: 25.99987907786385
Financial ratios for TT8.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 119.89583333333333
Shares outstanding: 426999732
Market cap (USD): 51195488701.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TT8.DE — annual report dated 2024-12-31
Total revenue: 2444831000
Gross profit: 1972819000
Operating income: 427167000
Net income: 393076000
Capital expenditures: 98238000
Operating cash flow: 739456000
Depreciation & amortization: 87490000
Net tangible assets: 2934524000
Owner earnings: 382328000
Return on net tangible assets (%): 13.028620655343081
Capex to operating income (%): 22.997563013996867
Buffett classification: The Great
Stock price: 119.89583333333333
P/E ratio: 130.24323210078967
Shares outstanding: 426999732
Book value: 2949145000
P/B ratio: 17.359434243229817
Market cap (USD): 51195488701.25
Debt to equity: 0.10586627649708645
Current ratio: 1.8571508614164431
Quick ratio: 1.8571508614164431
Effective tax rate (%): 22.5163709190975
COGS to revenue (%): 19.30652875393023
R&D to revenue (%): 18.95096225465073
SG&A to revenue (%): 44.27025835323587
Free cash flow (dilution-adjusted): 137695000
Buyback yield (%): 0.45860290810011833
Retained earnings: 354249000
Receivables turnover: 0.734107868168534
Capitalized R&D asset: 844780060
ROCI (R&D-adjusted, %): 12.053006737781208
Rosenberg metric: 0.9526535112216302
FCF margin (%): 5.632086635027124
Revenue growth (%): 25.625912071198076
Rule of 40 score: 31.2579987062252
Financial ratios for TT8.DE — quarterly report dated 2025-03-31
Total revenue: 616021000
Gross profit: 473182000
Operating income: 54452000
Net income: 50678000
Capital expenditures: 59113000
Operating cash flow: 291433000
Depreciation & amortization: 23985000
Net tangible assets: 2716684000
Owner earnings: 15550000
Return on net tangible assets (%): 0.5723889859843839
Capex to operating income (%): 108.559832513039
Buffett classification: The Gruesome
Stock price: 54.42391304347826
P/E ratio: 114.64045682523245
Shares outstanding: 426999732
Book value: 2716684000
P/B ratio: 8.554177182166391
Market cap (USD): 23238996283.95652
Debt to equity: 0.12330031759306566
Current ratio: 1.8106721619410737
Quick ratio: 1.8106721619410737
Effective tax rate (%): 33.115126238963164
Interest coverage ratio: 144.81914893617022
COGS to revenue (%): 23.18735887250597
R&D to revenue (%): 21.493098449565842
SG&A to revenue (%): 46.480233628399034
Free cash flow (dilution-adjusted): 101407000
Buyback yield (%): 1.6620769472158958
Retained earnings: 4518000
Receivables turnover: 0.2018465048978875
Capitalized R&D asset: 132402000
ROCI (R&D-adjusted, %): 4.522493797890284
FCF margin (%): 16.461614133284417
Rule of 40 score: 16.461614133284417
Financial ratios for TT8.DE — quarterly report dated 2025-06-30
Total revenue: 694039000
Gross profit: 543059000
Operating income: 116777000
Net income: 90129000
Capital expenditures: 45239000
Operating cash flow: 165013000
Depreciation & amortization: 26704000
Net tangible assets: 2695833000
Owner earnings: 71594000
Return on net tangible assets (%): 2.6557283036449215
Capex to operating income (%): 38.73964907473218
Buffett classification: The Good
Stock price: 72.72941176470589
P/E ratio: 86.14163957229933
Shares outstanding: 426999732
Book value: 2695833000
P/B ratio: 11.519793448647249
Market cap (USD): 31055439332.047062
Debt to equity: 0.12743704821478186
Current ratio: 1.713713943514105
Quick ratio: 1.713713943514105
Effective tax rate (%): 32.33609357287107
COGS to revenue (%): 21.753820750707092
R&D to revenue (%): 19.343437472533964
SG&A to revenue (%): 42.07703025334311
Free cash flow (dilution-adjusted): -12190000
Buyback yield (%): 0.8399269358615322
Retained earnings: -162356000
Receivables turnover: 0.21322845376889302
Capitalized R&D asset: 222960340
ROCI (R&D-adjusted, %): 5.017154594391059
Rosenberg metric: 0.5277639310584432
FCF margin (%): -1.756385448080007
Revenue growth (%): 12.66482798476026
Rule of 40 score: 10.908442536680253
Financial ratios for TT8.DE — quarterly report dated 2025-09-30
Total revenue: 739433000
Gross profit: 577279000
Operating income: 161219000
Net income: 115547000
Capital expenditures: 66336000
Operating cash flow: 224686000
Depreciation & amortization: 33135000
Net tangible assets: 2600786000
Owner earnings: 82346000
Return on net tangible assets (%): 3.166196680541959
Capex to operating income (%): 41.146514988928104
Buffett classification: The Good
Stock price: 48.847058823529416
P/E ratio: 81.36280700373426
Shares outstanding: 426999732
Book value: 2600786000
P/B ratio: 8.019760574932077
Market cap (USD): 20857681026.635296
Debt to equity: 0.1445628360041926
Current ratio: 1.7097420804462178
Quick ratio: 1.7097420804462178
Effective tax rate (%): 35.63522524078231
COGS to revenue (%): 21.92950544538856
R&D to revenue (%): 17.296090382766256
SG&A to revenue (%): 38.97134696449847
Free cash flow (dilution-adjusted): 33680000
Buyback yield (%): 1.4884061157305006
Retained earnings: -364445000
Receivables turnover: 0.2125822734880854
Capitalized R&D asset: 261533830
ROCI (R&D-adjusted, %): 4.913895111702687
Rosenberg metric: 0.25489568047910255
FCF margin (%): 4.554841344651916
Revenue growth (%): 6.540554637419511
Rule of 40 score: 11.095395982071427
Financial ratios for TT8.DE — annual report dated 2025-12-31
Total revenue: 2896284000
Gross profit: 2277217000
Operating income: 589321000
Net income: 443304000
Capital expenditures: 197011000
Operating cash flow: 992721000
Depreciation & amortization: 115784000
Net tangible assets: 2464462000
Owner earnings: 362077000
Return on net tangible assets (%): 14.69192870492627
Capex to operating income (%): 33.430167939034924
Buffett classification: The Good
Stock price: 38.352941176470594
P/E ratio: 36.9423592021834
Shares outstanding: 426999732
Book value: 2484391000
P/B ratio: 6.5918350226533216
Market cap (USD): 16376695603.764708
Debt to equity: 0.1756285544425173
Current ratio: 1.6108416511099062
Quick ratio: 1.6108416511099062
Effective tax rate (%): 32.705785914338406
COGS to revenue (%): 21.374526807453964
R&D to revenue (%): 18.1315437298276
SG&A to revenue (%): 40.14644282121505
Free cash flow (dilution-adjusted): 292331000
Buyback yield (%): 8.429185187289344
Retained earnings: -590912000
Receivables turnover: 0.76820556183581
Capitalized R&D asset: 971456750
ROCI (R&D-adjusted, %): 16.785810397109703
Rosenberg metric: 0.6569944250073924
FCF margin (%): 10.093312672376053
Revenue growth (%): 18.465611733489965
Rule of 40 score: 28.558924405866016